Other Names for this Disease
- Myoclonic epilepsy with choreoathetosis
- Naito Oyanagi disease
- Haw River syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
There is no cure for DRPLA; treatment is generally symptomatic and supportive. Management of signs and symptoms may include:
- Treatment of seizures with anti-epileptic drugs
- Treatment of psychiatric problems with appropriate psychotropic medications
- Adaptation of environment and care to the level of dementia
- Adaptation of educational programs for affected children.
Last updated: 9/5/2012
- Brice A. Dentatorubral pallidoluysian atrophy. Orphanet. 2004; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=101. Accessed 5/10/2010.
- Shoji Tsuji. DRPLA. GeneReviews. June 1, 2010; http://www.ncbi.nlm.nih.gov/books/NBK1491/. Accessed 9/5/2012.
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.
- The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research. Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the "Text Search" box. Then click "Submit Query".